Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal

Background Post Kala-azar Dermal Leishmaniasis (PKDL) develops in patients apparently cured of Visceral Leishmaniasis (VL), and is the strongest contender for being the disease reservoir. Therefore, existence of a few cases is sufficient to trigger an epidemic of VL in a given community, emphasizing the need for its active detection and in turn ensuring success of the current elimination program. This study explored the impact of active surveillance on the demographic profile of PKDL patients in West Bengal. Methodology/Principal findings Patients with PKDL were recruited through passive (2003-date, n = 100) and active surveillance (2015-date, n = 202), the former from outpatient departments of dermatology in medical colleges in West Bengal and the latter through an active door-to-door survey in four VL hyper-endemic districts of West Bengal. Passive surveillance indicated a male preponderance and a predominance of polymorphic lesions, whereas active surveillance indicated absence of any gender bias and more importantly, macular PKDL constituted almost 50% of the population burden. In terms of polymorphic vs. macular PKDL, the former appeared at a later age, their disease duration was longer and had a higher parasite burden. In the polymorphic variant, the lesional distribution was asymmetrical, comprised of papules/nodules/macules that were present mainly in sun-exposed areas whereas in macular cases, the hypopigmented patches were diffusely present all over the body. Conclusions/Significance Active surveillance unraveled a disease component whose demographic profile showed important differences with PKDL cases who sought treatment in government hospitals. Detection of a higher proportion of macular cases indicates that this variant is not an uncommon presentation as conventionally stated in text books, and should be studied in greater detail to ensure success of the ongoing Leishmaniasis elimination programme.

[1]  F. Gay,et al.  Leishmaniasis , 2019, The Lancet.

[2]  L. Coffeng,et al.  Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Chatterjee,et al.  Monitoring of Parasite Kinetics in Indian Post–Kala-azar Dermal Leishmaniasis , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  T. Hollingsworth,et al.  Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India , 2017, Parasites & Vectors.

[5]  B. Arana,et al.  Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme. , 2017, PLoS neglected tropical diseases.

[6]  D. Ghosh,et al.  Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  E. Zijlstra The immunology of post-kala-azar dermal leishmaniasis (PKDL) , 2016, Parasites & Vectors.

[8]  S. Roy,et al.  A male preponderance in patients with Indian post kala‐azar dermal leishmaniasis is associated with increased circulating levels of testosterone , 2016, International journal of dermatology.

[9]  S. Selim,et al.  A Study on Health Seeking Behaviors of Patients of Post-Kala-Azar Dermal Leishmaniasis , 2015, BioMed research international.

[10]  A. Mishra,et al.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study , 2015, BMC Public Health.

[11]  A. Maji,et al.  PKDL—A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India , 2015, PLoS neglected tropical diseases.

[12]  Jane E. Dalton,et al.  M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis , 2015, PLoS neglected tropical diseases.

[13]  M. Ramam,et al.  Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients. , 2015, Indian journal of dermatology, venereology and leprology.

[14]  S. Sundar,et al.  Parasite load estimation by qPCR differentiates between asymptomatic and symptomatic infection in Indian visceral leishmaniasis. , 2014, Diagnostic microbiology and infectious disease.

[15]  G. Matlashewski,et al.  Impact of ASHA Training on Active Case Detection of Visceral Leishmaniasis in Bihar, India , 2014, PLoS neglected tropical diseases.

[16]  Jane E. Dalton,et al.  Post kala-azar dermal leishmaniasis: an unresolved mystery , 2014, Trends in parasitology.

[17]  P. Das,et al.  Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India , 2014, PLoS neglected tropical diseases.

[18]  N. Das Chapter-11 Post-kala-azar Dermal Leishmaniasis: An Update , 2014 .

[19]  P. Desjeux,et al.  Report of the Post Kala-Azar Dermal Leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27–29 June 2012 , 2013, Parasites & Vectors.

[20]  A. Ranjan,et al.  Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India. , 2012, American Journal of Tropical Medicine and Hygiene.

[21]  S. Sundar,et al.  Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis , 2012, PLoS neglected tropical diseases.

[22]  D. Singh,et al.  Post-Kala-Azar Dermal Leishmaniasis in a Patient Treated with Injectable Paromomycin for Visceral Leishmaniasis in India , 2012, Journal of Clinical Microbiology.

[23]  S. Rijal,et al.  Post-Kala-azar Dermal Leishmaniasis in Nepal: A Retrospective Cohort Study (2000–2010) , 2011, PLoS neglected tropical diseases.

[24]  S. Roy,et al.  Case Report: Case Series of Misdiagnosis with rK39 Strip Test in Indian Leishmaniasis , 2011 .

[25]  G. Katara,et al.  Foxp3 and IL-10 Expression Correlates with Parasite Burden in Lesional Tissues of Post Kala Azar Dermal Leishmaniasis (PKDL) Patients , 2011, PLoS neglected tropical diseases.

[26]  R. Haque,et al.  Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh , 2010, PLoS neglected tropical diseases.

[27]  M. Chatterjee,et al.  Post‐kala‐azar dermal leishmaniasis – an overview , 2010, International journal of dermatology.

[28]  L. C. Singh,et al.  Quantification of Parasite Load in Clinical Samples of Leishmaniasis Patients: IL-10 Level Correlates with Parasite Load in Visceral Leishmaniasis , 2010, PloS one.

[29]  P. Salotra,et al.  Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine , 2009, Annals of tropical medicine and parasitology.

[30]  G J Ebrahim,et al.  Neglected tropical diseases , 2005, BMJ : British Medical Journal.

[31]  J. Alvar,et al.  Complexities of Assessing the Disease Burden Attributable to Leishmaniasis , 2008, PLoS neglected tropical diseases.

[32]  S. Croft PKDL--a drug related phenomenon? , 2008, The Indian journal of medical research.

[33]  P. Salotra,et al.  Challenges in the diagnosis of post kala-azar dermal leishmaniasis. , 2006, The Indian journal of medical research.

[34]  A. Fairlamb,et al.  Drug Resistance in Leishmaniasis , 2006, Clinical Microbiology Reviews.

[35]  S. Croft,et al.  Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. , 2003, Trends in parasitology.

[36]  E. Zijlstra,et al.  Post-kala-azar dermal leishmaniasis. , 2003, The Lancet. Infectious diseases.

[37]  S. Sundar Drug resistance in Indian visceral leishmaniasis , 2001, Tropical medicine & international health : TM & IH.

[38]  D M Wolpert,et al.  Earthquakes, influenza and cycles of Indian kala-azar. , 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.